Avandamet Uses
Links shared publicly online about this topic
Rosiglitazone maleate (marketed as Avandia, Avandamet, and Avandaryl) Information
fda.gov — “Rosiglitazone maleate (marketed as Avandia, Avandamet, and Avandaryl) Information” View full resource at fda.gov
Most Recently Shared on February 22, 2010 at 7:46 pm By:
eyeonfda Pharma and Health Lawyer
RT @mhuckman: New FDA communication (just posted) on Avandia. $GSK http://tinyurl.com/pmfdaava
European Medicines Agency Update On Ongoing Benefit-Risk Review Of Avandia, Avandamet And Avaglim
medicalnewstoday.com — “The European Medicines Agency is currently reviewing rosiglitazone to determine the impact of new data, from recent publications on the risk of cardiovascular problems, on the benefit- risk profil” View full resource at medicalnewstoday.com
Most Recently Shared on July 23, 2010 at 3:06 pm By:
MNT Cardiovascular Health News
European Medicines Agency Update On Ongoing Benefit-Risk Review Of Avandia, Avandamet And Avaglim http://mnt.to/3GtX #cardiovascular
CHMP Meets To Discuss Avandia And Pandemrix, Europe
medicalnewstoday.com — “The Committee for Medicinal Products for Human Use (CHMP) met on Wednesday 8 September to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia, Avandamet and A” View full resource at medicalnewstoday.com
Most Recently Shared on September 9, 2010 at 1:26 pm By:
MedicalNewsToday: CHMP Meets To Discuss Avandia And Pandemrix, Europe http://bit.ly/d3sOPJ Full http://bit.ly/agmp1v
Avandia (rosiglitazone) To Be Taken Off The Market In Europe
medicalnewstoday.com — “Avandia (rosiglitazone), and all diabetes medications that contain rosiglitazone will be taken off the market within the next few months, says the European Medicines Agency (EMA) which has recomme” View full resource at medicalnewstoday.com
Most Recently Shared on September 24, 2010 at 3:53 pm By:
Avandia (rosiglitazone) To Be Taken Off The Market In Europe http://bit.ly/cd1gV4
FDA Drug Safety Communication: Updated Risk Evaluation and Mitigation Strategy (REMS) to Restrict Access to Rosiglitazone-containing Medicines including Avandia, Avandamet, and Avandaryl
fda.gov — “The U.S. Food and Drug Administration (FDA) is informing the public of new restrictions to the prescribing and use of rosiglitazone-containing medicines.” View full resource at fda.gov
Most Recently Shared on May 18, 2011 at 6:06 pm By:
Updated Risk Evaluation & Mitigation Strategy to Restrict Access to Rosiglitazone-containing Medicines (FDA) http://1.usa.gov/lwECEi
Metformin: Oral Medication for Type 2 Diabetes - Metformin and Diabetes
diabetes.about.com — “Metformin (brand names Fortamet, Glucophage, Glumteza, Glucophage XR, Riomet) is an oral medication used alone or with other medications to treat type 2 diabetes. It is also available as the combination drug rosiglitazone/metformin (Avandamet).” View full resource at diabetes.about.com
Most Recently Shared on August 19, 2010 at 11:06 am By:
Metformin: Metformin (brand names Fortamet, Glucophage, Glumteza, Glucophage XR, Riomet) is an oral medication use... http://bit.ly/auRGtL
CHMP Meets To Discuss Avandia And Pandemrix, Europe - QualityPoint Technologies
qualitypointtech.net — “The Committee for Medicinal Products for Human Use (CHMP) met on Wednesday 8 September to discuss the ongoing benefit-risk review of the rosiglitazone-containing medicines Avandia, Avandamet and Avaglim. The Committee discussed all of the available data on the risk of cardiovascular problems associated with rosiglitazone in order to prepare for its next scheduled meeting of 20-23 September 2010, when it expects to finalise its review. The CHMP identified a number of further questions that it is ” View full resource at qualitypointtech.net
Most Recently Shared on September 9, 2010 at 2:09 pm By:
CHMP Meets To Discuss Avandia And Pandemrix, Europe: The Committee for Medicinal Products for Human Use (CHMP) met... http://bit.ly/bKsMhe
FDA restricts access to Avandia, cites increased cardiovascular risks - - Drug Topics
drugtopics.modernmedicine.com — “FDA has determined to significantly restrict the use of formulations that contain rosiglitazone (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline) to patients with Type 2 diabetes who cannot control their diabetes with other medications.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on October 7, 2010 at 3:08 pm By:
Endocrinology Wisdom OW Health
FDA restricts access to Avandia, cites increased cardiovascular risks: FDA has determined to significantly restric... http://bit.ly/c3pNkN
FDA restricts access to Avandia, cites increased cardiovascular risks - - Drug Topics
drugtopics.modernmedicine.com — “FDA has determined to significantly restrict the use of formulations that contain rosiglitazone (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline) to patients with Type 2 diabetes who cannot control their diabetes with other medications.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on October 9, 2010 at 2:59 pm By:
FDA restricts access to Avandia, cites increased cardiovascular risks: FDA has determined to significantly restric... http://bit.ly/btJ26f
Symposier - Stronger Warnings about Heart Failure for Certain Diabetes Drugs
symposier.com — “Uploaded and Shared in Youtube by:hkllp The manufacturers of thiazolidinedione drugs have strengthened warnings about the risks of heart failure with these medications, which are use to treat type 2 diabetes. They are sold as Avandia (rosiglitazone maleate), Avandaryl (rosiglitazone maleate and glimepiride), and Avandamet (rosiglitazone maleate and metformin hydrochloride), which all contain rosiglitazone, and Actos (pioglitazone hydrochloride), Duetact (pioglitazone hydrochloride and glimepr” View full resource at symposier.com
Most Recently Shared on December 4, 2009 at 4:47 am By:
Symposier Cardiology Cardiology and Health Business
Heart Failure related to certain diabetes drugs -->http://bit.ly/6GfnO9 // Shared at Symposier site // Good night !!
Avandia (Rosiglitazone) To Be Taken Off The Market In Europe - QualityPoint Technologies
qualitypointtech.net — “Avandia (rosiglitazone), and all diabetes medications that contain rosiglitazone will be taken off the market within the next few months, says the European Medicines Agency (EMA) which has recommended taking it off the market. Specifically, the following brands are involved - Avandia, Avandamet and Avaglim. Yesterday, the FDA (Food and Drug Administration, USA) severely restricted rosiglitazone use and ordered GlaxoSmithKline, the makers and sellers of the drug, to convene an independent group o” View full resource at qualitypointtech.net
Most Recently Shared on September 25, 2010 at 10:24 am By:
Avandia (Rosiglitazone) To Be Taken Off The Market In Europe: Avandia (rosiglitazone), and all diabetes medication... http://bit.ly/d9Dn8I
GSK revises US Avandia label to include new restrictions on use
gsk.com — “GlaxoSmithKline (GSK) today announced revised US prescribing information and medication guides for all rosiglitazone-containing medicines (Avandia®, Avandamet® and Avandaryl®) to include additional safety information and restrictions on the use of these medicines.” View full resource at gsk.com
Most Recently Shared on February 7, 2011 at 8:04 pm By:
Gannett Healthcare Health News
Breaking news: GSK revises US Avandia label to include new restrictions on use http://tinyurl.com/4gbods8
GSK revises US Avandia label to include new restrictions on use
gsk.com — “GlaxoSmithKline (GSK) today announced revised US prescribing information and medication guides for all rosiglitazone-containing medicines (Avandia®, Avandamet® and Avandaryl®) to include additional safety information and restrictions on the use of these medicines.” View full resource at gsk.com
Most Recently Shared on February 8, 2011 at 12:53 am By:
GSK revises US Avandia label to include new restrictions on use: GlaxoSmithKline (GSK) today announced revised U... http://bit.ly/ihJcNE
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
MNT Cardiovascular
The latest cardiovascular news published daily. Articles from research centers, universities and prestigious journals.
-
Heart Health
Get the latest news, information, and research on your heart. Re-tweet if you want.
Advertisement
